2005

Seidler J, Durzok R, Brakebusch C, Cordes N. Interactions of the integrin subunit ß1A with protein kinase B/Akt, p130Cas and paxillin contribute to regulation of radiation survival. Radiother Oncol, 2005, 76(2): 129-134

Cordes N, Meineke V. Modification of the cellular radiation survival and proliferation response by cell-matrix interactions: Implications for integrin targeting in therapeutic approaches for radiation accident patients. Brit J Radiol, 2005, 27: 152-156

2004

Lisiak E, Cordes N. Integrins and the cellular radiation response. Cancer Ther, 2004, 2: 271-278

Cordes N, Beinke C. Fibronectin alters cell survival and intracellular signaling of confluent A549 cultures after irradiation. Cancer Biol Ther, 2004, 3(1): 47-53

Cordes N. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity. Cancer Res, 2004, 64(16): 5683-5692

Cordes N, Meineke V. Integrin signaling and the cellular response to ionizing radiation. J Mol Histol, 2004, 35(3): 327-337

Cordes N, Beinke C. Fibronectin alters A549 human lung cancer cell survival after irradiation. Cancer Biol Ther, 2004, 3: 47-53

Cordes N, van Beuningen D. Arrest of human lung fibroblasts in G2 phase after irradiation is regulated by converging phosphatidylinositol-3 kinase and ß1-integrin signaling in vitro. Int J Radiat Oncol Biol Phys, 2004, 58: 453-462

Cordes N, Beinke C, Plasswilm L, van Beuningen D. Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and ß1-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitro. Strahlenther Onkol, 2004, 180(3):157-164

Meineke V, Müller K, Ridi R, Cordes N, Köhn FM, Mayerhofer A, Ring J, van Beuningen D. Development and evaluation of an organ model for the analysis of radiation effects. Strahlenther Onkol, 2004, 180: 102-108 

Meineke V, Müller K, Ridi R, Cordes N, Köhn FM, Mayerhofer A, Ring J, van Beuningen D. Development and evaluation of a skin organ model for the analysis of radiation effects. Strahlenther Onkol, 2004, 180(2): 102-8.